Skip to main content
Technology in Cancer Research & Treatment logoLink to Technology in Cancer Research & Treatment
. 2024 May 1;23:15330338241240520. doi: 10.1177/15330338241240520

Retracted: “CRISPR/Cas9: A Revolutionary Genome Editing Tool for Human Cancers Treatment”

PMCID: PMC11067681  PMID: 38693665

At the request of Sage and the Executive Editor, the following article has been retracted:

Akram F, Haq I ul, Sahreen S, et al. CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment. Technology in Cancer Research & Treatment. 2022;21. DOI:10.1177/15330338221132078

Sage was made aware of a PubPeer post that highlights concerns about non-standard language and phrases in this article.

When we contacted the authors for comment, they explained that they used these words to avoid plagiarism in their article from their cited texts.

Due to the outstanding concerns about the authenticity of this research, the Managing Editor retracts this article.

F.A. disagrees with the retraction. All other authors did not respond when notified.


Articles from Technology in Cancer Research & Treatment are provided here courtesy of SAGE Publications

RESOURCES